Hypericin in the dark inhibits key steps of angiogenesis in vitro

European Journal of Pharmacology

Volumn 516, Issue 2, 2005, Pages 97-103

  Martínez Poveda, Beatriz ^a   Quesada, Ana R ^a   Medina, Miguel Ángel ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Angiogenesis inhibitor; Bovine endothelial cells; Hypericin; St. John's wort

Indexed keywords

GELATINASE; HYPERICIN; MATRIGEL; UROKINASE;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; COW; DARKNESS; DRUG EFFECT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLUOROMETRY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; ZYMOGRAPHY;

ANGIOGENESIS INHIBITORS; ANIMALS; CAPILLARIES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DARKNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIAL CELLS; LAMININ; MATRIX METALLOPROTEINASE 2; PERYLENE; PROTEOGLYCANS; RADIATION-SENSITIZING AGENTS; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 20444372636     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.03.047     Document Type: Article

References (39)

1. P. Agostinis, A. Vantieghem, W. Merlevede, and P.A.M. de Witte Hypericin in cancer treatment: more light on the way Int. J. Biochem. Cell Biol. 34 2002 221 241
2. M. Blank, M. Mandel, S. Hazan, Y. Keisari, and G. Lavie Anti-cancer activities of hypericin in the dark Photochem. Photobiol. 74 2001 120 125
3. M. Blank, G. Lavie, M. Mandel, S. Hazan, A. Orenstein, D. Meruelo, and Y. Keisari Antimetastatic activity of the photodynamic agent hypericin in the dark Int. J. Cancer 111 2004 593 603
4. P. Carmeliet Angiogenesis in health and disease Nat. Med. 9 2003 653 660
5. M.E. Castro, M. González-Iriarte, A.F. Barrero, N. Salvador-Tormo, R. Muñoz-Chápuli, M.A. Medina, and A.R. Quesada Study of puupehenone and related compounds as inhibitors of angiogenesis Int. J. Cancer 110 2004 31 38
6. E. Delaey, A. Vandenbogaerde, W. Merlevede, and P. de Witte Photocytotoxicity of hypericin in normoxic and hypoxic conditions J. Photochem. Photobiol. 56 2000 19 24
7. G. Di Carlo, F. Borrelli, E. Ernst, and A.A. Izzo St. John's wort. Prozac from the plant kingdom Trends Pharmacol. Sci. 2 2001 292 297
8. O. Dormond, A. Foletti, C. Paroz, and C. Ruegg NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis Nat. Med. 7 2001 1041 1047
9. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat. Rev., Cancer 2 2002 163 176
10. I. Fajardo, A.R. Quesada, I. Núñez de Castro, F. Sanchez-Jimenez, and M.A. Medina A comparative study of the effects of genistein and 2-methoxyestradiol on the proteolytic balance and tumour cell proliferation Br. J. Cancer 80 1999 17 24
11. R. García de Veas, L. Schweigerer, and M.A. Medina Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein Eur. J. Cancer 34 1998 1736 1740
12. M. Gourly, and J.S. Williamson Angiogenesis: new targets for the development of anticancer chemotherapies Curr. Pharm. Des. 6 2000 417 439
13. J.M. Greeson, B. Sanford, and D.A. Monti St. John's wort (Hypericum perforatum): a review of the current pharmacological, toxicological and clinical literature Psychopharmacology 153 2001 402 414
14. J. Griggs, J.C. Metcalfe, and R. Hesketh Targeting tumor vasculature: the development of combretastatin A4 Lancet Oncol. 2 2001 82 87
15. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
16. A.L. Harris Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy Recent Results Cancer Res. 152 1998 341 352
17. T. Hisa, Y. Kimura, K. Takada, F. Suzuki, and M. Takigawa Shikonin, an ingredient of Lithospermum erythrorhizon, inhibits angiogensis in vivo and in vitro Anticancer Res. 18 1998 782 790
18. K. Igura, T. Ohta, Y. Kuroda, and K. Kaji Resveratrol and quercetin inhibit angiogenesis in vitro Cancer Lett. 171 2001 11 16
19. D. Ingber, T. Fujita, S. Kishimoto, K. Sudo, T. Kanamaru, H. Brem, and J. Folkman Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Nature 348 1990 555 557
20. J.A. Kang, J.T. Kim, H.S. Song, M.K. Bae, E.Y. Yi, K.W. Kim, and Y.J. Kim Anti-angiogenic and anti-tumor invasive activites of tissue inhibitor of metalloproteinase-3 from shark, Scyliorhinus torazame Biochim. Biophys. Acta 1620 2003 59 64
21. M.S. Kim, Y.M. Lee, E.J. Moon, S.E. Kim, J.J. Lee, and K.W. Kim Antiangiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica Int. J. Cancer 87 2000 269 275
22. H. Kimura, M.S. Harris, T. Sakamoto, R. Gopalakrishna, U. Gundimeda, J.Z. Cui, C. Spee, D.R. Hinton, and S.J. Ryan Hypericin inhibits choroidal endothelial cell proliferation and cord formation in vitro Curr. Eye Res. 16 1997 967 972
23. G.M. Kitanov Hypericin and pseudohypericin in some Hypericum species Biochem. Syst. Ecol. 29 2001 171 178
24. L.A. Liotta, P.S. Steeg, and W.G. Stetler-Stevenson Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell 64 1991 327 336
25. D. Meruelo, G. Lavie, and D. Lavie Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin Proc. Natl. Acad. Sci. U. S. A. 85 1988 5230 5234
26. L. Miccoli, A. Beurdeley-Thomas, G. De Pinieux, F. Sureau, S. Oudard, B. Dutrillaux, and M.F. Poupon Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria Cancer Res. 58 1998 5777 5786
27. M.A. Moses, and R. Langer Inhibitors of angiogenesis Biotechnology 9 1991 630 634
28. E.M. Paleolog, and J.M. Miotla Angiogenesis in arthritis: role in disease pathogenesis and as a potential therapeutic target Angiogenesis 2 1998 295 307
29. K.A. Peebles, R.K. Baker, E.U. Kurz, B.J. Schneider, and D.J. Kroll Catalytic inhibition of human DNA topoisomerase IIα by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum) Biochem. Pharmacol. 62 2001 1059 1070
30. M.S. Pepper, D. Belin, R. Montesano, L. Orci, and J.D. Vasalli Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro J. Cell Biol. 111 1990 743 755
31. J.M. Rakic, C. Maillard, M. Jost, K. Bajou, V. Masson, L. Devy, V. Lambert, J.M. Foidart, and A. Noël Role of plasminogen activator-plasmin system in tumor angiogenesis Cell. Mol. Life Sci. 60 2003 463 473
32. S. Rodríguez-Nieto, M. González-Iriarte, R. Carmona, R. Muñoz-Chápuli, M.A. Medina, and A.R. Quesada Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge FASEB J. 2001 10.1096/fj.01-0427fje
33. S. Rodríguez-Nieto, M.A. Medina, and A.R. Quesada A re-evaluation of fumagillin selectivity towards endothelial cells Anticancer Res. 21 2001 3457 3460
34. M. Shimamura, T. Hazato, H. Ashino, Y. Yamamoto, E. Iwasaki, H. Tobe, K. Yamamoto, and S. Yamamoto Inhibition of angiogenesis by humulone, a bitter acid from beer hop Biochem. Biophys. Res. Commun. 289 2001 220 224
35. W.G. Stetler-Stevenson Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention J. Clin. Invest. 103 1999 1237 1241
36. J. Tang, J.M. Colacino, S.H. Larsen, and W. Spitzer Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses Antivir. Res. 13 1990 313 326
37. D. Thaloor, A.K. Singh, G.S. Sidhu, P.V. Prasad, H.K. Kleinman, and R.K. Maheswari Inhibition of angiogenic differentiation of human umbilical endothelial cells by curcumin Cell Growth Differ. 9 1998 305 312
38. X. Xie, J.B. Hudson, and E.S. Guns Tumor-specific and photodependent cytotoxicity of hypericin in the human LNCaP prostate tumor model Photochem. Photobiol. 74 2001 221 225
39. W. Zhang, R.E. Law, D.R. Hinton, and W.T. Couldwell Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor Cancer Lett. 120 1997 31 38